GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MRUS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Merus NV stock price ended at $39.81 on Friday, after losing 1.63%.
(Updated on Apr 19, 2024)

Sell candidate since Apr 16, 2024 Loss -1.24% PDF

The Merus NV stock price fell by -1.63% on the last day (Friday, 19th Apr 2024) from $40.47 to $39.81. During the last trading day the stock fluctuated 7.91% from a day low at $39.27 to a day high of $42.38. The price has fallen in 8 of the last 10 days and is down by -10.94% for this period. Volume has increased on the last day by 555 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 792 thousand shares were bought and sold for approximately $31.52 million.

Given the current short-term trend, the stock is expected to rise 14.73% during the next 3 months and, with a 90% probability hold a price between $45.67 and $63.95 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MRUS Signals & Forecast

There are few to no technical positive signals at the moment. The Merus NV stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $41.12 and $44.83. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -23.18%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Merus NV stock

On the downside, the stock finds support just below today's level from accumulated volume at $36.19 and $36.14. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Merus NV finds support just below today's level at $36.19. If this is broken, then the next support from accumulated volume will be at $36.14 and $34.04.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.11 between high and low, or 7.91%. For the last week, the stock has had daily average volatility of 4.58%.

Merus NV is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MRUS) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Merus NV to open at $40.49, and during the day (based on 14 day Average True Range), to move between $38.08 and $41.54, which gives a possible trading interval of +/-$1.73 (+/-4.35%) up or down from last closing price. If Merus NV takes out the full calculated possible swing range there will be an estimated 8.69% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $40.06 (0.63%) than the support at $36.19 (9.09%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Merus NV stock A Buy?

The Merus NV stock holds several negative signals and despite the positive trend, we believe Merus NV will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.534 Sell Candidate Unchanged

Predicted Opening Price for Merus NV of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$40.49 ( 1.70%) $39.81

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MRUS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 43.59 9.50 %
R2 42.40 6.52 %
R1 41.67 4.67 %
Current price: 39.81
Support S1 39.30 -1.28 %
S2 38.57 -3.12 %
S3 37.38 -6.10 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 46.03 15.62 %
R2 44.91 12.81 %
R1 40.06 0.628 %
Current price 39.81
Support S1 36.19 -9.09%
S2 36.14 -9.22%
S3 34.04 -14.49%

FAQ

What is the symbol for Merus NV Stock and on which exchange is it traded?
The symbol for Merus NV is MRUS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Merus NV Stock?
The Merus NV stock holds several negative signals and despite the positive trend, we believe Merus NV will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Merus NV Stock?
Merus NV Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Merus NV Stock.

What's the current price of Merus NV Stock?
As of the end of day on the 2024-04-19, the price of an Merus NV (MRUS) share was $39.81.

What is the 52-week high and low for Merus NV Stock?
The 52-week high for Merus NV Stock is $52.04 and the 52-week low is $18.21.

What is the market capitalization of Merus NV Stock?
As of the 2024-04-19, the market capitalization of Merus NV is 2.304B.

When is the next earnings date for Merus NV?
The upcoming earnings date for Merus NV is May 02, 2024.
Click to get the best stock tips daily for free!

About Merus NV

Merus NV Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also de... MRUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT